Arbutus Biopharma Corp — Director's Dealing 2021

Nov 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arbutus Biopharma Corp (ABUS)
CIK: 0001447028
Period of Report: 2021-11-09

Reporting Person: Tran Tram (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-09	Stock Option (Right to Buy)	$3.5	A	44000	Acquired	2031-11-09	Common Shares (44000.0)	Direct

Footnotes

F1: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on November 9, 2021, the date of the grant.

F2: The option will vest and become exercisable in three equal annual installments beginning one year from the grant date.